Hiroaki Nishikawa Selected Research

Hiroaki Nishikawa Research Topics

Disease

27	Coronary Artery Disease (Coronary Atherosclerosis) 03/2023 - 11/2002
13	Myocardial Infarction 08/2016 - 07/2002
12	Pathologic Constriction (Stenosis) 01/2017 - 10/2003
10	Stable Angina 02/2018 - 07/2002
9	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 07/2002
8	Atherosclerosis 02/2021 - 01/2004
6	Coronary Restenosis 08/2016 - 10/2003
5	Coronary Stenosis (Coronary Artery Stenosis) 11/2020 - 10/2003
5	Acute Coronary Syndrome 02/2018 - 01/2005
5	Diabetes Mellitus 08/2016 - 01/2011
4	Hypertension (High Blood Pressure) 02/2021 - 02/2004
4	Thrombosis (Thrombus) 02/2013 - 12/2009
3	Heart Failure 05/2017 - 01/2006
2	Dyslipidemias (Dyslipidemia) 02/2021 - 12/2020
2	Hypercholesterolemia 09/2009 - 12/2008
1	Inflammation (Inflammations) 03/2023
1	Body Weight (Weight, Body) 05/2017
1	Neoplasms (Cancer) 01/2017
1	Ovarian Neoplasms (Ovarian Cancer) 01/2017
1	Anterior Wall Myocardial Infarction 07/2016
1	Hyperglycemia 05/2015
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 12/2014
1	Pulmonary Hypertension 12/2014
1	Atherosclerotic Plaque (Atheroma) 01/2013
1	Chest Pain (Chest Pains) 04/2012
1	Hypoadiponectinemia 11/2011
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2011
1	Rupture 01/2008
1	Hyperlipidemias (Hyperlipidemia) 01/2005

Drug/Important Bio-Agent (IBA)

12	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020 - 02/2004
8	LDL CholesterolIBA 02/2021 - 01/2006
8	LipidsIBA 11/2020 - 01/2006
6	oxidized low density lipoproteinIBA 02/2021 - 12/2008
5	CholesterolIBA 01/2017 - 09/2006
4	HDL CholesterolIBA 02/2021 - 06/2009
4	Angiotensin Receptor AntagonistsIBA 05/2017 - 03/2005
3	Triglycerides (Triacylglycerol)IBA 02/2021 - 06/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2017 - 06/2003
3	olmesartanIBA 01/2013 - 07/2009
3	AdiponectinIBA 11/2011 - 02/2009
3	Valsartan (Vals)FDA Link 09/2011 - 01/2007
3	Chemokine ReceptorsIBA 01/2008 - 10/2003
3	ChemokinesIBA 01/2008 - 10/2003
2	C-Reactive ProteinIBA 03/2023 - 01/2006
2	Hemoglobins (Hemoglobin)IBA 02/2021 - 06/2009
2	HDL LipoproteinsIBA 08/2016 - 05/2003
2	MetalsIBA 08/2016 - 01/2008
2	omega-Chloroacetophenone (Mace)IBA 02/2015 - 01/2011
2	Atorvastatin (Lipitor)FDA Link 08/2012 - 08/2012
2	Angiotensin II Type 1 Receptor BlockersIBA 07/2009 - 03/2006
2	Pravastatin (Pravachol)FDA LinkGeneric 12/2008 - 11/2002
2	Cell Adhesion MoleculesIBA 01/2004 - 01/2004
1	Blood Glucose (Blood Sugar)IBA 02/2021
1	von Willebrand FactorIBA 04/2018
1	Coloring Agents (Dyes)IBA 04/2018
1	Tolvaptan FDA Link 05/2017
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 01/2017
1	DiamondIBA 10/2016
1	Amlodipine (Norvasc)FDA LinkGeneric 10/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	Bosentan (Tracleer)FDA Link 12/2014
1	Gallium-68IBA 01/2013
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2013
1	apolipoprotein A-I MilanoIBA 01/2013
1	Irbesartan FDA LinkGeneric 01/2013
1	ApolipoproteinsIBA 01/2013
1	Peptides (Polypeptides)IBA 01/2013
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2013
1	PTX3 proteinIBA 08/2012
1	Ezetimibe (Zetia)FDA Link 08/2012
1	Glycated Serum AlbuminIBA 01/2012
1	pentosidineIBA 09/2011
1	pigment epithelium-derived factorIBA 09/2011
1	Biomarkers (Surrogate Marker)IBA 09/2011
1	BilirubinIBA 01/2011
1	Hydroxyurea (Hydrea)FDA LinkGeneric 12/2009
1	Rosuvastatin Calcium (Crestor)FDA Link 09/2009
1	Antihypertensive Agents (Antihypertensives)IBA 07/2009
1	Fatty Acid-Binding ProteinsIBA 01/2009
1	Simvastatin (Zocor)FDA LinkGeneric 12/2008
1	Sirolimus (Rapamycin)FDA Link 01/2008
1	Losartan (Cozaar)FDA LinkGeneric 01/2007
1	CXCR ReceptorsIBA 01/2006
1	Carvedilol (Coreg)FDA LinkGeneric 01/2006
1	CC ChemokinesIBA 01/2006
1	Arginine (L-Arginine)FDA Link 01/2006
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2006

Therapy/Procedure

16	Stents 02/2018 - 01/2005
11	Therapeutics 12/2020 - 07/2002
9	Percutaneous Coronary Intervention 01/2018 - 01/2009
3	Renal Dialysis (Hemodialysis) 02/2018 - 01/2004
3	Drug-Eluting Stents 01/2017 - 02/2013
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2012 - 02/2007
2	Glycemic Control 05/2015 - 01/2011
1	Secondary Prevention 12/2020
1	Cardiac Rehabilitation 12/2014
1	Injections 01/2013
1	Aftercare (After-Treatment) 04/2012
1	Bed Rest (Bedrest) 01/2008